Cargando…

The impact of body mass index on age at breast cancer diagnosis and breast cancer phenotype

Detalles Bibliográficos
Autores principales:	Brouckaert, Olivier, Poppe, An, Laenen, Annouschka, Floris, Giuseppe, Leunen, Karin, Berteloot, Patrick, Amant, Frederic, Vergote, Ignace, Smeets, Ann, Weltens, Caroline, Peeters, Stephanie, Van Limbergen, Erik, Wildiers, Hans, Christiaens, Marie-Rose, Neven, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582251/ http://dx.doi.org/10.1186/2049-3258-73-S1-P6

Ejemplares similares

Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection?
por: Smeets, Ann, et al.
Publicado: (2013)

Update on triple-negative breast cancer: prognosis and management strategies
por: Brouckaert, Olivier, et al.
Publicado: (2012)

Biological ageing and frailty markers in breast cancer patients
por: Brouwers, Barbara, et al.
Publicado: (2015)

Impact of tumor chronology and tumor biology on lymph node metastasis in breast cancer
por: Smeets, Ann, et al.
Publicado: (2013)

Validation of a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer()
por: Van der Vorst, Aline, et al.
Publicado: (2022)

Impact of baseline telomere length on survival and chemotherapy related toxicity in breast cancer patients receiving (neo)adjuvant anthracycline containing chemotherapy
por: Hatse, Sigrid, et al.
Publicado: (2022)

Immune profiles of elderly breast cancer patients are altered by chemotherapy and relate to clinical frailty
por: Bailur, Jithendra Kini, et al.
Publicado: (2017)

Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3
por: De Cock, L., et al.
Publicado: (2021)

Age‐related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancer
por: Berben, Lieze, et al.
Publicado: (2020)

Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy
por: Dalmasso, Bruna, et al.
Publicado: (2018)

Oncological safety of autologous breast reconstruction after mastectomy for invasive breast cancer
por: Geers, Joachim, et al.
Publicado: (2018)

Effect of manual lymph drainage in addition to guidelines and exercise therapy on arm lymphoedema related to breast cancer: randomised controlled trial
por: Devoogdt, Nele, et al.
Publicado: (2011)

Correlation of TROP-2 expression with clinical–pathological characteristics and outcome in triple-negative breast cancer
por: Izci, Hava, et al.
Publicado: (2022)

Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer
por: Lambrechts, Sandrina, et al.
Publicado: (2015)

Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?
por: Vandenput, I, et al.
Publicado: (2009)

Circulating biomarkers at diagnosis correlate with distant metastases of early luminal-like breast cancer
por: Lambrechts, Yentl, et al.
Publicado: (2023)

Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer
por: Van Nieuwenhuysen, Els, et al.
Publicado: (2019)

Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma
por: Amant, F, et al.
Publicado: (2007)

Short-Term Prognostic Index for Breast Cancer: NPI or Lpi
por: Van Belle, V., et al.
Publicado: (2010)

Circulating MicroRNAs as Easy-to-Measure Aging Biomarkers in Older Breast Cancer Patients: Correlation with Chronological Age but Not with Fitness/Frailty Status
por: Hatse, Sigrid, et al.
Publicado: (2014)

Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer
por: Vos, Hanne, et al.
Publicado: (2021)

Dynamic alterations of immunosenescence-related genes in older women with breast cancer receiving chemotherapy: A prospective study
por: Wu, Qi, et al.
Publicado: (2022)

The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters
por: Brouwers, Barbara, et al.
Publicado: (2016)

Blood Immunosenescence Signatures Reflecting Age, Frailty and Tumor Immune Infiltrate in Patients with Early Luminal Breast Cancer
por: Berben, Lieze, et al.
Publicado: (2021)

The footprint of the ageing stroma in older patients with breast cancer
por: Brouwers, Barbara, et al.
Publicado: (2017)

Tenckhoff tunneled peritoneal catheter placement in the palliative treatment of malignant ascites: technical results and overall clinical outcome
por: Maleux, Geert, et al.
Publicado: (2016)

Cause of death for patients with breast cancer: discordance between death certificates and medical files, and impact on survival estimates
por: Izci, Hava, et al.
Publicado: (2021)

Retrospective Cohort Study of Practical Applications of Paramagnetic Seed Localisation in Breast Carcinoma and Other Malignancies
por: Clement, Céline, et al.
Publicado: (2022)

Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management
por: van Schooneveld, Eleni, et al.
Publicado: (2015)

Postpartum breast cancer: mechanisms underlying its worse prognosis, treatment implications, and fertility preservation
por: Lefrère, Hanne, et al.
Publicado: (2021)

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers
por: van Schooneveld, Eleni, et al.
Publicado: (2012)

Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors
por: Lambrechts, Yentl, et al.
Publicado: (2023)

Pre-treatment ADC histogram-analysis at whole body diffusion-weighted MRI predicts disease free survival in ovarian cancer
por: Michielsen, K, et al.
Publicado: (2015)

Can ADCs broaden the treatment landscape of metastatic ER+/HER2− breast cancer resistant to CDK4/6 inhibition?
por: Van Baelen, Karen, et al.
Publicado: (2023)

The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers
por: Moens, Stijn, et al.
Publicado: (2021)

Mortality and Major Adverse Cardiac Events in Patients With Breast Cancer Receiving Radiotherapy: The First Decade
por: Jacobs, Johanna E. J., et al.
Publicado: (2023)

Matrix Metalloproteinase Expression Patterns in Luminal A Type Breast Carcinomas
por: Decock, J., et al.
Publicado: (2007)

The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1–98 trial
por: Desmedt, Christine, et al.
Publicado: (2009)

Postpartum breast cancer behaves differently
por: Van den Rul, N., et al.
Publicado: (2011)

Data describing the poor outcome associated with a breast cancer diagnosis in the post-weaning period
por: Lefrère, Hanne, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6jg9ah3o188u1vfta80m08tm8f